These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2129822)

  • 1. Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction.
    Jalihal A; Kurian G
    J Gastroenterol Hepatol; 1990; 5(5):507-13. PubMed ID: 2129822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double blind study of ispaghula in irritable bowel syndrome.
    Prior A; Whorwell PJ
    Gut; 1987 Nov; 28(11):1510-3. PubMed ID: 3322956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.
    Kumar A; Kumar N; Vij JC; Sarin SK; Anand BS
    Gut; 1987 Feb; 28(2):150-5. PubMed ID: 3030900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psyllium therapy in the irritable bowel syndrome. A double-blind trial.
    Longstreth GF; Fox DD; Youkeles L; Forsythe AB; Wolochow DA
    Ann Intern Med; 1981 Jul; 95(1):53-6. PubMed ID: 7018336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
    Kim HJ; Camilleri M; McKinzie S; Lempke MB; Burton DD; Thomforde GM; Zinsmeister AR
    Aliment Pharmacol Ther; 2003 Apr; 17(7):895-904. PubMed ID: 12656692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breath methane in functional constipation: response to treatment with Ispaghula husk.
    Vega AB; Perelló A; Martos L; García Bayo I; García M; Andreu V; Abad A; Barenys M
    Neurogastroenterol Motil; 2015 Jul; 27(7):945-53. PubMed ID: 25952409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo].
    Tomás-Ridocci M; Añón R; Mínguez M; Zaragoza A; Ballester J; Benages A
    Rev Esp Enferm Dig; 1992 Jul; 82(1):17-22. PubMed ID: 1520545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging.
    Major G; Murray K; Singh G; Nowak A; Hoad CL; Marciani L; Silos-Santiago A; Kurtz CB; Johnston JM; Gowland P; Spiller R
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13400. PubMed ID: 30062794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.
    Hebden JM; Blackshaw E; D'Amato M; Perkins AC; Spiller RC
    Am J Gastroenterol; 2002 Sep; 97(9):2315-20. PubMed ID: 12358250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
    Chiba T; Kudara N; Sato M; Chishima R; Abiko Y; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial.
    Misra SP; Thorat VK; Sachdev GK; Anand BS
    Q J Med; 1989 Oct; 73(270):931-9. PubMed ID: 2697886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.
    Arthurs Y; Fielding JF
    Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome.
    Gorard DA; Libby GW; Farthing MJ
    Aliment Pharmacol Ther; 1994 Apr; 8(2):159-66. PubMed ID: 8038347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
    Cann PA; Read NW; Holdsworth CD
    Gut; 1983 Dec; 24(12):1135-40. PubMed ID: 6357963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation.
    Dettmar PW; Sykes J
    Curr Med Res Opin; 1998; 14(4):227-33. PubMed ID: 9891195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission.
    Hallert C; Kaldma M; Petersson BG
    Scand J Gastroenterol; 1991 Jul; 26(7):747-50. PubMed ID: 1654592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of plantago seed husks in comparison with wheat brain on stool frequency and manifestations of irritable colon syndrome with constipation].
    Hotz J; Plein K
    Med Klin (Munich); 1994 Dec; 89(12):645-51. PubMed ID: 7869999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of oligofructose in the management of irritable bowel syndrome.
    Hunter JO; Tuffnell Q; Lee AJ
    J Nutr; 1999 Jul; 129(7 Suppl):1451S-3S. PubMed ID: 10395619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.